Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Relationship between N-terminal pro brain natriuretic peptide and dry weight in maintain hemodialysis patients
    LI Jie;ZHANG Qi-meng;FAN Min-hua
    null    2011, 10 (7): 377-380.  
    Abstract595)   HTML31)    PDF(pc) (211KB)(8234)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2014, 13 (10): 729-732.   DOI: 10.3969/j.issn.1671-4091.2014.10.013
    Abstract480)   HTML19)    PDF(pc) (284KB)(4083)      
    Related Articles | Metrics
    Guideline on the management of hyperkalemia in maintenance hemodialysi patients in China
    Expert group of guideline on the management of hyperkalemia in maintenance hemodialysis patients in China
    Chinese Journal of Blood Purification    2022, 21 (增刊): 1-16.   DOI: 10.3969/j.issn.1671-4091.2022.S.001
    Abstract2071)      PDF(pc) (905KB)(3265)      
    Reference | Related Articles | Metrics
    Chinese Journal of Blood Purification    DOI: 10.3969/j.issn.1671-4091.2019.06.001
    Accepted: 03 January 2020

    Chinese Journal of Blood Purification    2019, 18 (07): 442-472.   DOI: 10.3969/j.issn.1671-4091.2019.07.002
    Abstract883)      PDF(pc) (731KB)(3068)      
    Related Articles | Metrics
    Clinical practice guideline for use of iron on anemia in chronic kidney disease
    Committee of clinical practice guideline for use of iron on anemia in chronic kidney disease
    Chinese Journal of Blood Purification    2022, 21 (增刊): 17-40.   DOI: 10.3969/j.issn.1671-4091.2022.S.002
    Abstract1170)      PDF(pc) (1508KB)(3054)      
    Related Articles | Metrics
    Prevention and treatment of hypotension during hemodialysis
    CAI Li;ZUO Li
    null    2008, 7 (1): 3-5.  
    Abstract631)   HTML8)    PDF(pc) (467KB)(2786)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2015, 14 (06): 375-378.   DOI: 10.3969/j.issn.1671-4091.2015.06.014
    Abstract262)   HTML1)    PDF(pc) (572KB)(2635)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2022, 21 (01): 59-62.   DOI: 10.3969/j.issn.1671-4091.2022.01.014
    Abstract458)      PDF(pc) (448KB)(2579)      
    Reference | Related Articles | Metrics
    Interpretation of the KDOQI Clinical Practice Guideline for Vascular Access, 2019 version
    Chinese Journal of Blood Purification    2020, 19 (07): 482-491.   DOI: 10.3969/j.issn.1671-4091.2020.07.013
    Abstract1437)      PDF(pc) (468KB)(2489)      
    【Abstract】In April 2020, the American National Kidney Foundation made a major update to the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline for Vascular Access, and carried out various treatments for the survival plan of end-stage renal disease patients, including the life plan of end-stage renal disease patients, the selection of vascular access, and the new methods for handling specific complications. This article interprets this guideline according to the conditions of our country, helps doctors and patients make decisions on the treatment mode and vascular access for end-stage renal disease, and brings
    directional suggestions for subsequent research.
    Reference | Related Articles | Metrics
    Chinese Journal of Blood Purification    2018, 17 (11): 769-772.   DOI: 10.3969/j.issn.1671-4091.2018.11.012
    Abstract449)      PDF(pc) (281KB)(2459)      
    Related Articles | Metrics
    null    2006, 5 (4): 205-207.  
    Abstract434)   HTML1)    PDF(pc) (261KB)(2428)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2014, 13 (12): 841-844.   DOI: 10.3969/j.issn.1671-4091.2014.12.010
    Abstract202)   HTML1)    PDF(pc) (264KB)(2416)      
    Related Articles | Metrics
    The developmental history of peritoneal dialysis in China in the 70 years
    Chinese Journal of Blood Purification    2019, 18 (10): 661-663.   DOI: 10.3969/j.issn.1671-4091.2019.10.001
    Abstract1023)      PDF(pc) (391KB)(2398)      
    【Abstract】There are about 1,000,000~2,000,000 patients with end-stage renal disease (ESRD) in China, which consumes huge medical resources and results in great economic burden to the society. Peritoneal dialysis (PD) has the advantages of convenience, safe, effective and home treatment, becoming one of the alternative treatment methods suitable for ESRD patients in China. The number of registered PD patients increases nearly 20 times from 4,380 in 1999 to 86,264 by the end of 2018. With the improvement of dialysis registration system, the widespread utilization of standard PD operating protocols, and the increase of high- quality clinical studies on PD in China, we have achieved continuous advances in PD quality, large experiences in treatment and management of PD, and excellent reputations about the treatment of PD in the international community.
    Related Articles | Metrics
    null    2008, 7 (11): 618-621.  
    Abstract516)   HTML2)    PDF(pc) (292KB)(2391)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2013, 12 (08): 458-461.  
    Abstract374)   HTML5)    PDF(pc) (1324KB)(2385)      
    Related Articles | Metrics
    null    2008, 7 (7): 399-402.  
    Abstract550)   HTML1)    PDF(pc) (487KB)(2382)      
    Related Articles | Metrics
    null    2005, 4 (7): 349-351.  
    Abstract354)   HTML7)    PDF(pc) (256KB)(2306)      
    Related Articles | Metrics
    null    2006, 5 (11): 792-794.  
    Abstract423)   HTML1)    PDF(pc) (248KB)(2255)      
    Related Articles | Metrics
    Hemodialysis and hypertension
    WU Hua
    null    2008, 7 (1): 1-3.  
    Abstract462)   HTML0)    PDF(pc) (456KB)(2214)      
    Related Articles | Metrics
    null    2008, 7 (9): 494-497.  
    Abstract640)   HTML1)    PDF(pc) (485KB)(2172)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2015, 14 (01): 47-50.   DOI: 10.3969/j.issn.1671-4091.2015.01.012
    Abstract313)   HTML5)    PDF(pc) (288KB)(2151)      
    Related Articles | Metrics
    Studies on the target values of serum calcium, phosphorus and PTH for the treatment of chronic kidney disease-mineral and bone disorder
    Ya-ping FAN
    Chinese Journal of Blood Purification    2017, 16 (06): 367-369.   DOI: 10.3969/j.issn.1671-4091.2017.06.003
    Abstract520)      PDF(pc) (374KB)(2124)      
    Chronic kidney disease- mineral and bone disorder (CKD-MBD) is a common complication during the progression of CKD, closely relating to the hospitalization rate, poor quality of life, cardiovascular calcification and cardiovascular or all- cause mortality in CKD patients. It is an important issue for clinical workers to identify the CKD-MBD related control targets of serum calcium, phosphorus and PTH values, and a series of clinical guidelines and consensus have been provided in the past years. The target values for serum calcium and phosphorus are basically consistent, i.e. to achieve and maintain the values in the normal reference ranges when possible. The calcium-phosphorus product is mainly affected by the phosphorus concentration and has less significance. The target value for PTH is quite broad. The suggestion in KDIGO guidelines that intact PTH (iPTH) should be controlled in 2-9 times of the upper normal limit is widely mentioned but is controversial. However, a narrow range for iPTH cannot be defined in the published results so far. Clinically, the dynamic changes of CKD-MBD parameters are more valuable than a single value of one parameter.
    Related Articles | Metrics
    null    2005, 4 (12): 657-659.  
    Abstract658)   HTML4)    PDF(pc) (303KB)(2069)      
    Objective To study the effect of midodrine to prevent the hemodialysis-related hypotension (IDH) in maintained-hemodialysis (MHD) patients. Methods 27 MHD patients who had usually showed IDH were involved. These patients received hemodialysis with the same hemodialysis prescription, but took orally Midodrine 7.5~15mg for three times every day, and took orally another 5mg at 30 minutes before hemodialysis or onset of IDH. Blood pressure and IDH were observed during hemodialysis. Results Ultrafiltration rate, pre-hemodialysis blood pressure, temperature and sodium concentration of dialysate were no significant difference between before and after Midodrine treatment in 27 cases (P>0.05). After Midodrine treatment, total ultrafiltrated volumes, the lowest intrahemodialysis blood pressure, and post-hemodialysis blood pressure were increased significantly (P<0.05), and the cases showed IDH, symptomatic IDH were reduced(P <0.01). Midodrine treatment showed significant effect in 11 cases (40.7% ), showed effect in 9 (33.3%), and showed no effect in 7 (26.0%). Conclusion We suggest that Midodrine treatment can effectively prevent hemodialysis-related hypotension in MHD patients.
    Related Articles | Metrics
    Syphilis Laboratory Tests and Interpretation of Results
    Chinese Journal of Blood Purification    2017, 16 (10): 661-663.   DOI: 10.3969/j.issn.1671-4091.2017.010.005
    Abstract395)      PDF(pc) (298KB)(2036)      
    The incidence of syphilis has gradually increased in recent years, laboratory test is important for the correct diagnosis of syphilis .This paper has reviewed the clinical characteristics and laboratory test progress in syphilis diagnosis, especially in Nontreponemal tests and treponemal tests for syphilis infection diagnosis
    and laboratory test results interpretation for clinical use.
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2013, 12 (01): 56-57.  
    Abstract305)   HTML10)    PDF(pc) (131KB)(1997)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2016, 15 (07): 369-371.   DOI: 10.3969/j.issn.1671-4091.2016.07.013
    Abstract281)   HTML4)    PDF(pc) (326KB)(1972)      
    Related Articles | Metrics
    null    2007, 6 (9): 500-502.  
    Abstract452)   HTML2)    PDF(pc) (240KB)(1972)      
    Related Articles | Metrics
    Chinese Journal of Blood Purification    2015, 14 (01): 5-9.   DOI: 10.3969/j.issn.1671-4091.2015.01.002
    Abstract783)   HTML17)    PDF(pc) (343KB)(1955)      
    Related Articles | Metrics
    The developmental history of blood purification–hemodialysis
    Chinese Journal of Blood Purification    2019, 18 (07): 439-441.   DOI: 10.3969/j.issn.1671-4091.2019.07.001
    Abstract1053)      PDF(pc) (385KB)(1948)      
    【Abstract】Hemodialysis has been developed for more than one hundred years since the modern concept of dialysis was established. Currently, hemodialysis has become an important modality of renal replacement therapy in clinical practice. Here we summarize the developmental history of hemodialysis with emphasis on the progress in China in the recent 70 years, from which it is anticipated that more advanced hemodialysis technologies will arise in the nearly future period.
    Related Articles | Metrics
    A review of iron metabolism, laboratory assessment and strategy for iron management
    Chinese Journal of Blood Purification    2020, 19 (03): 157-160.   DOI: 10.3969/j.issn.1671-4091.2020.03.004
    Abstract528)      PDF(pc) (414KB)(1934)      
    【Abstract】Iron is a vital trace element for humans. The amount of iron in the body has to be maintained in an ideal range. The absorption of dietary iron and the transport of iron are complex processes critical for iron homeostasis. The reticuloendothelial system is responsible for iron recycling through phagocytosis of the erythrocytes. Hepcidin is a liver-derived peptide hormone and an important regulator of iron metabolism. This hormone acts in many target tissues and regulates iron level in the body through a negative feedback mechanism. Serum ferritin is a fundamental index to reflec iron metabolism situation in the body. In chronic inflammatory conditions, higher thresholds of ferritin concentration and transferrin saturation, and other laboratory examinations such as soluble and serum transferrin receptors and hepcidin are required for the evaluation of this disease conditions. The best evidences and experiences should be referred in the determination of the iron supplementation strategy for iron deficiency in inflammation and chronic kidney disease.
    Reference | Related Articles | Metrics
    null    2007, 6 (12): 642-644.  
    Abstract405)   HTML1)    PDF(pc) (241KB)(1930)      
    Related Articles | Metrics
    Epidemiology and treatment pattern of hyperkalemia among outpatients in China: a descriptive study using an administrative database in China 
    Chinese Journal of Blood Purification    2020, 19 (11): 726-729.   DOI: 10.3969/j.issn.1671-4091.2020.11.002
    Abstract1210)      PDF(pc) (392KB)(1873)      
    【Abstract】Objectives The aim of this study was to evaluate the proportion of hyperkalemia, rates of the diagnosis and treatment, and rate of retesting for hyperkalemia among outpatients in China. Methods Data were derived from Beijing Data Center for Rational Use of Drugs. Patients who accessed outpatient services (aged ≥18 years old) with record(s) of serum potassium (S-K) between Jan. 1st, 2015 and Dec. 31st, 2017 were included. The data about laboratory test, diagnosis and treatment were analyzed. The main outcomes including proportion of hyperkalemia patients, diagnosis rate, treatment rate and S-K retesting rate were analyzed. The geographic and seasonal distributions of the outcomes were examined. Results A total of 2,997,634 patients with at least one S-K record were analyzed. Among these patients, 115,826 (3.86%) experienced hyperkalemia (S-K>5.0mmol/L). In patients with chronic kidney disease, heart failure, diabetes mellitus and hypertension, the rates of patients who experienced hyperkalemia were 22.89%, 12.54%, 7.11% and 6.51%, respectively. In outpatients, the overall rate of hyperkalemia was 2.53%. In patients with hyperkalemia, the overall hyperkalemia treatment rate was 8.69%, and the overall retesting rate within 7 days was 11.41%. Conclusions Hyperkalemia is an abnormality not rare in adult outpatients in China. The rate and severity of hyperkalemia were higher in patients with chronic kidney disease, heart failure, hypertension and diabetes
    compared to those in the overall outpatients. However, the rates of diagnosis, treatment and retesting for hyperkalemia in outpatients were insufficient, suggesting that the recognition and management of hyperkalemia in outpatients should be emphasized.
    Reference | Related Articles | Metrics
    The technical issues in clinical application of plasma exchange
    Chinese Journal of Blood Purification    2021, 20 (05): 289-293.   DOI: 10.3969/j.issn.1671-4091.2021.05.001
    Abstract721)      PDF(pc) (437KB)(1865)      
    【Abstract】Plasma exchange (PE) is a blood purification method aiming at removing circulating pathogenic proteins or protein-bound substances, which has been widely applied in treating various diseases, including autoimmune diseases. It has two technical forms: membrane separation(MPE) and centrifugal separation (CPE). The technical issues include prescription of treatment dose and frequency, choice of plasma separator, setup of treatment parameters including blood flow rate, plasma separation rate, choice of replacement fluid, anticoagulation, prevention of clinical and technical complications. In this paper, we reviewed all of the issues mentioned above in detail.
    Reference | Related Articles | Metrics
    Chinese Journal of Blood Purification   
    li wang
    Chinese Journal of Blood Purification    2013, 12 (10): 528-530.  
    Abstract200)   HTML1)    PDF(pc) (262KB)(1813)      
    Related Articles | Metrics
    The research progress of nutritional therapy for chronic kidney disease
    Chinese Journal of Blood Purification    2020, 19 (04): 259-262.   DOI: 10.3969/j.issn.1671-4091.2020.04.013
    Abstract345)      PDF(pc) (310KB)(1791)      
    Reference | Related Articles | Metrics
    Chinese Journal of Blood Purification    2015, 14 (09): 562-565.   DOI: 10.3969/j.issn.1671-4091.2015.09.013
    Abstract285)   HTML0)    PDF(pc) (261KB)(1770)      
    Related Articles | Metrics
    The clinical significance of transmembrane pressure monitoring in hemodialysis
    Chinese Journal of Blood Purification    2018, 17 (07): 490-493.   DOI: 10.3969/j.issn.1671-4091.2018.07.015
    Abstract626)      PDF(pc) (396KB)(1754)      
    【Abstract】This paper analyzes the causes of transmembrane pressure change and its unfavorable effects. We focuse on the principle of transmembrane pressure monitoring in dialysis machine. We particularly emphasize the training for medical staffs about the importance of transmembrane pressure monitoring and the manipulation of relevant preventive measures to achieve safe and efficient use of dialysis.
    Related Articles | Metrics
    Pathogenesis, prevention and treatment of muscle cramps in hemodialysis
    Chinese Journal of Blood Purification    2017, 16 (07): 446-450.   DOI: 10.3969/j.issn.1671-4091.2017.07.004
    Abstract529)      PDF(pc) (389KB)(1750)      
    Muscle cramps is one of the most common complications in hemodialysis, leading to lower tolerance and adequacy of the dialysis treatment. Here we review the pathogenesis, prevention and treatment of muscle cramps in hemodialysis in order to find out effective treatment for patients suffered from this complication.
    Related Articles | Metrics